STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment
Manoj Chelvanambi(University of Pittsburgh), Walter J. Storkus(University of Pittsburgh)
Cited by 177
Related Papers
IL‐4 inhibits VLA‐4 expression on Tc1 cells resulting in poor tumor infiltration and reduced therapy benefit
|European Journal of Immunology|2008|23